Continuous bile delivery to the intestine reshapes the bile acid pool, perturbs FXR-FGF19/TGR5 pathways, remodels gut microbiota, and compromises epithelial barrier integrity, collectively promoting portal endotoxemia, chronic hepatic inflammation, and fibrogenic remodeling. The gene discussed is FGF19; the disease is inflammation.